Adverse events associated with pediatric exposures to dextromethorphan

References

• Lovegrove MC, Weidle NJ, Budnitz DS. Trends in emergency department visits for unsupervised pediatric medication exposures, 2004–2013. Pediatrics. 2015;136:e821–e829.
   PubMed Web of Science ®Google Scholar
• Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J Pediatr. 2012;160:265–270e1.
   PubMed Web of Science ®Google Scholar
• Ferguson RW, Osterhaler K, Kaminski S, et al. Medicine safety for children: an in-depth look at poison center calls. Washington (DC): Safe Kids Worldwide; 2015.
   Google Scholar
• Dart RC, Paul IM, Bond GR, et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med. 2009;53:411–417.
   PubMed Web of Science ®Google Scholar
• Schaefer MK, Shehab N, Cohen AL, et al. Adverse events from cough and cold medications in children. Pediatrics. 2008;121:783–787.
   PubMed Web of Science ®Google Scholar
• Gunn VL, Taha SH, Liebelt EL, et al. Toxicity of over-the-counter cough and cold medications. Pediatrics. 2001;108:E52.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Cough, cold, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final monograph for OTC antitussive drug products. 21 CFR parts 310, 341, and 369. Federal Register 1987;52:30042–30057.
   Google Scholar
• Patterns of medication use in the United States: 2006. 2006 [Internet] [cited 2016 Jul 21]. Available from: http://www.bu.edu/slone/files/2012/11/SloneSurveyReport2006.pdf.
   Google Scholar
• Vernacchio L, Kelly JP, Kaufman DW, et al. Medication use among children <12 years of age in the United States: results from the Slone Survey. Pediatrics. 2009;124:446–454.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Cough, cold, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; proposed amendment to monograph for OTC antitussive drug products. 21 CFR part 341. Federal Register 1987; 57:58378–58381.
   Google Scholar
• Mazer-Amirshahi M, Rasooly I, Brooks G, et al. The impact of pediatric labeling changes on prescribing patterns of cough and cold medications. J Pediatr. 2014;165:1024–1028.e1.
   PubMed Web of Science ®Google Scholar
• Varney SM, Bebarta VS, Pitotti RL, et al. Survey in the emergency department of parents’ understanding of cough and cold medication use in children younger than 2 years. Pediatr Emerg Care. 2012;28:883–885.
   PubMed Web of Science ®Google Scholar
• Garbutt JM, Sterkel R, Banister C, et al. Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications. Acad Pediatr. 2010;10:64–69.
   PubMed Web of Science ®Google Scholar
• CS Mott Children’s Hospital. Parents ignore warning labels, give cough & cold meds to young kids. National Poll Children's Health [Internet]. 2013;18(2). Available from: http://mottnpch.org/sites/default/files/documents/042213_CoughColdMeds.pdf
   Google Scholar
• Berlin CM Jr, McCarver-May DG, Notterman DA, et al. Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics. 1997;99:918–920.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Transcript for the May 17, 2011 Joint meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Commitee. Silver Spring (MD): Food and Drug Administration, Center for Drug Evaluation Research; 2011.
   Google Scholar
• International Conference on Harmonisation, ICH Harmonised Tripartitie Guideline on Clincial Safety Data Management: Definitions and Standards for Expedited Reporting. [Internet] [cited 2016 Jun 1]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf.
   Google Scholar
• Paul IM, Shaffer ML, Yoder KE, et al. Dose–response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther. 2004;26:1508–1514.
   PubMed Web of Science ®Google Scholar
• Carr BC. Efficacy, abuse, and toxicity of over-the-counter cough and cold medicines in the pediatric population. Curr Opin Pediatr. 2006;18:184–188.
   PubMed Web of Science ®Google Scholar
• Graudins A, Fern RP. Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan containing cough and cold syrup. J Toxicol Clin Toxicol. 1996;34:351–352.
   Google Scholar
• Knowles SR, Weber E. Dextromethorphan anaphylaxis. J Allergy Clin Immunol. 1998;102:316–317.
   PubMed Web of Science ®Google Scholar
• Walker J, Yatham LN. Benylin (dextromethorphan) abuse and mania. BMJ. 1993;306:896.
   PubMed Web of Science ®Google Scholar
• Nairn SJ, Diaz JE. Cold-syrup induced movement disorder. Pediatr Emerg Care. 2001;17:191–192.
   PubMed Web of Science ®Google Scholar
• Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol. 2005;10:325–327.
   PubMed Web of Science ®Google Scholar
• Sharma A, Dewan V, Petty F. Acute psychosis with Coricidin cold medicine. Ann Pharmacother. 2005;39:1577–1578.
   PubMed Web of Science ®Google Scholar
• Dodds A, Revai E. Toxic psychosis due to dextromethorphan hydrobromide. Med J Aust. 1967;2:231.
   Google Scholar
• Shaul WL, Wandell M, Robertson WO. Dextromethorphan toxicity: reversal by naloxone. Pediatrics. 1977;59:117–118.
   PubMed Web of Science ®Google Scholar
• Romanelli F, Smith KM. Dextromethorphan abuse: clinical effects and management. J Am Pharm Assoc (2003). 2009;49:e20–e25. quiz e6–7.
   PubMed Web of Science ®Google Scholar
• Schwartz RH. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila). 2005;44:565–568.
   PubMed Web of Science ®Google Scholar
• Church J. Dextromethorphan, dysphoria and NMDA receptors. Neuromodulatory effects of dextromethorphan: role of NMDA receptors in responses. Trends Pharmacol Sci. 1990;11:146–147.
   PubMed Web of Science ®Google Scholar
• Church J, Sawyer D, McLarnon JG. Interactions of dextromethorphan with the N-methyl-d-aspartate receptor-channel complex: single channel recordings. Brain Res. 1994;666:189–194.
   PubMed Web of Science ®Google Scholar
• Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol (Phila). 2008;46:771–773.
   PubMed Web of Science ®Google Scholar
• Kamei J, Tanihara H, Igarashi H, et al. Effects of N-methyl-d-aspartate antagonists on the cough reflex. Eur J Pharmacol. 1989;168:153–158.
   PubMed Web of Science ®Google Scholar
• Canning BJ. Central regulation of the cough reflex: therapeutic implications. Pulm Pharmacol Ther. 2009;22:75–81.
   PubMed Web of Science ®Google Scholar
• Blake MJ, Gaedigk A, Pearce RE, et al. Ontogeny of dextromethorphan O- and N-demethylation in the first year of life. Clin Pharmacol Ther. 2007;81:510–516.
   PubMed Web of Science ®Google Scholar
• Zawertailo LA, Tyndale RF, Busto U, et al. Effect of metabolic blockade on the psychoactive effects of dextromethorphan. Hum Psychopharmacol. 2010;25:71–79.
   PubMed Web of Science ®Google Scholar
• Reissig CJ, Carter LP, Johnson MW, et al. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology. 2012;223:1–15.
   PubMed Web of Science ®Google Scholar
• Marcucci C, Sandson NB, Dunlap JA. Linezolid-bupropion interaction as possible etiology of severe intermittent intraoperative hypertension? Anesthesiology. 2004;101:1487–1488.
   PubMed Web of Science ®Google Scholar
• Hines RN. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol. 2007;21:169–175.
   PubMed Web of Science ®Google Scholar
• Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther. 2008;118:250–267.
   PubMed Web of Science ®Google Scholar
• Guenin E, Armogida M, Riff D. Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents. Clin Drug Investig. 2014;34:609–616.
   PubMed Web of Science ®Google Scholar
• Zawertailo LA, Kaplan HL, Busto UE, et al. Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study. J Clin Psychopharmacol. 1998;18:332–337.
   PubMed Web of Science ®Google Scholar
• Hampton LM, Nguyen DB, Edwards JR, et al. Cough and cold medication adverse events after market withdrawal and labeling revision. Pediatrics. 2013;132:1047–1054.
   PubMed Web of Science ®Google Scholar